Founded in November 2021, Polyseq Biotechnology established in Beijing to promote R&D and commercialization nanopore sequencer. Leveraging the principles of nanopore sequencing, the company integrates novel bio-nanopore structures resolved at the atomic level with nucleic acid chemistry, protein engineering, and other disciplines to establish a proprietary sequencing chemistry system. By combining integrated circuit chips, software engineering, and deep learning algorithms, Polyseq has developed a high-performance sequencing platform. Its mission is to deliver accurate, high-throughput, long-read, and cost-effective nanopore sequencers and consumables, bringing gene sequencing technology to healthcare institutions at all levels to democratize precision medicine and safeguard public health.
